Home World News InflaMix Identifies CAR-T Recipients with a Preinfusion Inflammatory Profile Indicative of High...

InflaMix Identifies CAR-T Recipients with a Preinfusion Inflammatory Profile Indicative of High Risk for CAR-T Treatment Failure

May 5, 2025

429

A valuable tool for point-of-care clinical decision-making in patients with non-Hodgkin lymphoma